SOLID CARCINOMA
Clinical trials for SOLID CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new SOLID CARCINOMA trials appear
Sign up with your email to follow new studies for SOLID CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to shrink Hard-to-Treat tumors
Disease control Recruiting nowThis early-phase study tests a new drug called INV-1120, either by itself or combined with pembrolizumab (Keytruda), in adults with advanced solid tumors that have stopped responding to standard treatments. The main goals are to find safe doses and check for side effects. About 7…
Matched conditions: SOLID CARCINOMA
Phase: PHASE1 • Sponsor: Shenzhen Ionova Life Sciences Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 05:34 UTC
-
New hope for advanced cancer: experimental drug DM005 enters first human trials
Disease control Recruiting nowThis early-phase trial tests an experimental drug, DM005, in about 136 people with advanced solid tumors (like lung, head and neck, or other cancers) that have not responded to standard treatments. The main goals are to check the drug's safety, find the best dose, and see how wel…
Matched conditions: SOLID CARCINOMA
Phase: PHASE1 • Sponsor: Doma Biopharmaceutical（Suzhou）Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 05:31 UTC
-
New drug DM002 enters first human tests for advanced cancers
Disease control Recruiting nowThis early-phase study tests a new drug called DM002 in 160 people with advanced solid tumors (ovarian, prostate, endometrial, colorectal, or other solid cancers). The study has two parts: first, finding a safe dose by testing low to higher doses in small groups; second, giving t…
Matched conditions: SOLID CARCINOMA
Phase: PHASE1 • Sponsor: Xadcera Biopharmaceutical (Suzhou) Co., Ltd. • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Can a poop pill help immunotherapy work again?
Disease control Recruiting nowThis study is for people with advanced solid cancers that stopped responding to standard immunotherapy. It tests whether a fecal microbiota transplant (FMT) — transferring healthy gut bacteria from a donor — combined with the drug nivolumab can shrink tumors. About 50 participant…
Matched conditions: SOLID CARCINOMA
Phase: NA • Sponsor: Asan Medical Center • Aim: Disease control
Last updated May 13, 2026 16:00 UTC
-
New pill targets hard-to-treat cancers with KRAS and BRAF mutations
Disease control Recruiting nowThis early-phase study tests an oral drug called S241656 in adults with advanced cancers that have certain gene changes (KRAS, BRAF, and others). The drug is given alone or with other cancer treatments. The goal is to find safe doses and see if the drug shrinks tumors. About 554 …
Matched conditions: SOLID CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Institut de Recherches Internationales Servier • Aim: Disease control
Last updated May 12, 2026 13:40 UTC
-
New hope for kids with resistant tumors: drug combo enters safety trial
Disease control Recruiting nowThis early-phase study tests a combination of two drugs, avutometinib and defactinib, in children and young adults (ages 3 to 30) with solid tumors that have returned or not responded to treatment. The main goal is to find a safe dose with manageable side effects. The drugs targe…
Matched conditions: SOLID CARCINOMA
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 06, 2026 16:15 UTC
-
New imaging agent could sharpen cancer detection
Diagnosis Recruiting nowThis study is testing a new type of PET scan that uses a special tracer to find a protein called Trop2 on cancer cells. The goal is to see if this scan can detect and monitor many types of solid tumors more accurately than current methods. About 400 adults with or suspected of ha…
Matched conditions: SOLID CARCINOMA
Phase: PHASE2, PHASE3 • Sponsor: RenJi Hospital • Aim: Diagnosis
Last updated May 15, 2026 11:56 UTC
-
Blood test may predict deadly clots in cancer patients
Knowledge-focused Recruiting nowThis study is looking at whether a blood test that measures a clotting factor called thrombin can predict which cancer patients are at risk for dangerous blood clots. The researchers will follow 200 adults with high-risk solid tumors (lung, pancreatic, stomach, or brain cancer) f…
Matched conditions: SOLID CARCINOMA
Phase: NA • Sponsor: Institut Cancerologie de l'Ouest • Aim: Knowledge-focused
Last updated May 17, 2026 05:32 UTC